Back to top
more

Humana (HUM)

(Delayed Data from NYSE)

$349.30 USD

349.30
1,583,481

-2.92 (-0.83%)

Updated May 24, 2024 04:00 PM ET

After-Market: $349.35 +0.05 (0.01%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.08%
2Buy17.91%
3Hold9.44%
4Sell5.10%
5Strong Sell2.55%
S&P50011.04%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

A Value B Growth C Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 27% (68 out of 250)

Industry: Medical - HMOs

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Brokerage Reports

Research for HUM

The Zacks Equity Research reports, or ZER for short, are our in-house, independently produced research reports.

The ever popular one-page Snapshot reports are generated for virtually every single Zacks Ranked stock. It's packed with all of the company's key stats and salient decision making information. Including the Zacks Rank, Zacks Industry Rank, Style Scores, the Price, Consensus & Surprise chart, graphical estimate analysis and how a stocks stacks up to its peers.

The detailed multi-page Analyst report does an even deeper dive on the company's vital statistics. In addition to all of the proprietary analysis in the Snapshot, the report also visually displays the four components of the Zacks Rank (Agreement, Magnitude, Upside and Surprise); provides a comprehensive overview of the company business drivers, complete with earnings and sales charts; a recap of their last earnings report; and a bulleted list of reasons to buy or sell the stock. It also includes an industry comparison table to see how your stock compares to its expanded industry, and the S&P 500.

Researching stocks has never been so easy or insightful as with the ZER Analyst and Snapshot reports.

Learn more about Zacks Equity Research reports

See more Zacks Equity Research reports

   

0 items in cart

Humana Inc. [HUM]

Reports for Purchase

Showing records 581 - 600 ( 661 total )

Company: Humana Inc.

Industry: Medical - HMOs

Record: 581

04/30/2012

Company Report

Pages: 13

Reiterate OUTPERFORM; Entering 2013 In an Even Stronger Position Post 2012 Investments

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 582

04/30/2012

Company Report

Pages: 6

Benefit Costs Outran Premium Increases

Provider: J.J.B. Hilliard, W.L. Lyons

Analyst: O'NEIL S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 583

04/30/2012

Daily Note

Pages: 6

Look for More Color on the Call for Disappointing Retail MLR; Reiterate OUTPERFORM Based on Undervalued Long-Term Growth Opportunity

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 584

04/16/2012

Financial Spreadsheet

Pages: 27

Model.

Provider: Dowling & Partners

Price: .00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 585

04/09/2012

Daily Note

Pages: 35

1Q12 Managed Care Preview: Supreme Ct Hearings Over & Positive Read by Street- Focus Shifts to Fundamentals

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 75.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 586

04/08/2012

Company Report

Pages: 8

Updating Estimates in Connection with 1Q12 Preview, based on Updated MA Enrollment

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 587

03/22/2012

Daily Note

Pages: 4

Ohio to Allow All Plans to Bid for Duals Opportunity

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 588

03/14/2012

Industry Report

Pages: 10

March Medicare Enrollment: HUM Better Than Expected- Could See Up To $0.07 Upside to our $8.32 2012E.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 589

03/13/2012

Industry Report

Pages: 9

Proprietary Primary Care Physician Survey Shows Some Initial Signs of Modest Utilization Increases in Certain Geographies.

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 590

03/01/2012

Company Report

Pages: 11

Price: 24.95

Company: Humana Inc.

Industry: Medical - HMOs

Record: 591

02/29/2012

Industry Report

Pages: 10

OBSERVATIONS ON BANKING IN KENTUCKY

Provider: J.J.B. Hilliard, W.L. Lyons

Analyst: DEMMERLE R

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 592

02/27/2012

Industry Report

Pages: 5

RADV Error Methodology Finalized, View Prospective Nature as a Positive; $370M in Projected Overpayments Just 0.3% of Total MA Spend

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 10.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 593

02/21/2012

Industry Report

Pages: 8

2013 Preliminary MA Rates Better Than Expected

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 594

02/13/2012

Financial Spreadsheet

Pages: 7

MODEL

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: .00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 595

02/09/2012

Financial Spreadsheet

Pages: 28

MODEL.

Provider: Dowling & Partners

Price: .00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 596

02/08/2012

Company Report

Pages: 16

Margins Likely to Compress in 2012 and 2013

Provider: Dowling & Partners

Analyst: GOULEKAS P

Price: 50.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 597

02/07/2012

Company Report

Pages: 12

Price: 24.95

Company: Humana Inc.

Industry: Medical - HMOs

Record: 598

02/06/2012

Company Report

Pages: 6

Strong Medicare Advantage Enrollment Gains

Provider: J.J.B. Hilliard, W.L. Lyons

Analyst: O'NEIL S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 599

02/06/2012

Daily Note

Pages: 7

First Look at 4Q11 In-Line; $0.10 Boost in Guidance Screens Conservative, Reiterate OUTPERFORM

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 25.00

Research Provided by a Third Party

Company: Humana Inc.

Industry: Medical - HMOs

Record: 600

02/06/2012

Company Report

Pages: 14

Reiterate OUTPERFORM; Sell-Off Creates Buying Opportunity for Stable Long-Term Growth Story

Provider: WEDBUSH SECURITIES INC.

Analyst: JAMES S

Price: 50.00

Research Provided by a Third Party